• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-338-3p 通过靶向 PTP1B 在胃癌中发挥肿瘤抑制作用。

miR-338-3p functions as a tumor suppressor in gastric cancer by targeting PTP1B.

机构信息

Department of General Surgery, Drum Tower Hospital, Medical School of Nanjing University, 321 Zhongshan Road, Nanjing, Jiangsu, 210008, China.

State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, NJU Advanced Institute for Life Sciences (NAILS), School of Life Sciences, Nanjing University, 163 Xianlin Road, Nanjing, Jiangsu, 210046, China.

出版信息

Cell Death Dis. 2018 May 1;9(5):522. doi: 10.1038/s41419-018-0611-0.

DOI:10.1038/s41419-018-0611-0
PMID:29743567
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5943282/
Abstract

Gastric cancer (GC) is one of the most common malignant tumors and peritoneal metastasis is the primary cause for advanced GC's mortality. Protein-tyrosine phosphatase 1B (PTP1B) functions as an oncogene and involves in carcinogenesis and cancer dissemination. However, the function and regulation of PTP1B in GC remain poorly understood. In this study, we found that PTP1B was upregulated in GC tissues and overexpression of PTP1B in vitro promoted cell migration and prevented apoptosis. Then, we predicted that PTP1B was a target of miR-338-3p and we revealed an inverse correlation between miR-338-3p levels and PTP1B protein levels in GC tissues. Next, we verified that PTP1B was inhibited by miR-338-3p via direct targeting to its 3'-untranslated regions. Moreover, overexpression of miR-338-3p in vitro attenuated GC cell migration and promoted apoptosis, and these effects could be partially reversed by reintroduction of PTP1B. Finally, we established an orthotopic xenograft model and a peritoneal dissemination model of GC to demonstrate that miR-338-3p restrained tumor growth and dissemination in vivo by targeting PTP1B. Taken together, our results highlight that PTP1B is an oncogene and is negatively regulated by miR-338-3p in GC, which may provide new insights into novel molecular therapeutic targets for GC.

摘要

胃癌(GC)是最常见的恶性肿瘤之一,腹膜转移是晚期 GC 患者死亡的主要原因。蛋白酪氨酸磷酸酶 1B(PTP1B)作为一种癌基因,参与了肿瘤的发生和癌症的扩散。然而,PTP1B 在 GC 中的功能和调节作用仍知之甚少。在本研究中,我们发现 PTP1B 在 GC 组织中上调,体外过表达 PTP1B 促进细胞迁移并阻止细胞凋亡。然后,我们预测 PTP1B 是 miR-338-3p 的靶标,并揭示了 miR-338-3p 水平与 GC 组织中 PTP1B 蛋白水平之间的负相关关系。接下来,我们通过直接靶向其 3'非翻译区验证了 PTP1B 受 miR-338-3p 的抑制。此外,体外过表达 miR-338-3p 可减弱 GC 细胞的迁移并促进细胞凋亡,而过表达 PTP1B 可部分逆转这些作用。最后,我们建立了 GC 的原位异种移植模型和腹膜转移模型,证明 miR-338-3p 通过靶向 PTP1B 抑制体内肿瘤的生长和转移。综上所述,我们的研究结果表明 PTP1B 是一种癌基因,在 GC 中受 miR-338-3p 的负调控,这可能为 GC 的新型分子治疗靶点提供新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/5943282/a5a9241219ca/41419_2018_611_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/5943282/6a60c22b5ffa/41419_2018_611_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/5943282/3651c14aba51/41419_2018_611_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/5943282/bb6d93b91d39/41419_2018_611_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/5943282/62dcf3ac5678/41419_2018_611_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/5943282/8929672de02a/41419_2018_611_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/5943282/3b60b4d0b5b3/41419_2018_611_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/5943282/1e1598391628/41419_2018_611_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/5943282/a5a9241219ca/41419_2018_611_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/5943282/6a60c22b5ffa/41419_2018_611_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/5943282/3651c14aba51/41419_2018_611_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/5943282/bb6d93b91d39/41419_2018_611_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/5943282/62dcf3ac5678/41419_2018_611_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/5943282/8929672de02a/41419_2018_611_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/5943282/3b60b4d0b5b3/41419_2018_611_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/5943282/1e1598391628/41419_2018_611_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d8/5943282/a5a9241219ca/41419_2018_611_Fig8_HTML.jpg

相似文献

1
miR-338-3p functions as a tumor suppressor in gastric cancer by targeting PTP1B.miR-338-3p 通过靶向 PTP1B 在胃癌中发挥肿瘤抑制作用。
Cell Death Dis. 2018 May 1;9(5):522. doi: 10.1038/s41419-018-0611-0.
2
Identification of miRNomes in human stomach and gastric carcinoma reveals miR-133b/a-3p as therapeutic target for gastric cancer.人类胃及胃癌中微小RNA组的鉴定揭示miR-133b/a-3p为胃癌的治疗靶点。
Cancer Lett. 2015 Dec 1;369(1):58-66. doi: 10.1016/j.canlet.2015.06.028. Epub 2015 Aug 11.
3
miR-487a promotes progression of gastric cancer by targeting TIA1.miR-487a 通过靶向 TIA1 促进胃癌的进展。
Biochimie. 2018 Nov;154:119-126. doi: 10.1016/j.biochi.2018.08.006. Epub 2018 Aug 23.
4
miR-324-3p promotes gastric cancer development by activating Smad4-mediated Wnt/beta-catenin signaling pathway.miR-324-3p 通过激活 Smad4 介导的 Wnt/β-catenin 信号通路促进胃癌的发展。
J Gastroenterol. 2018 Jun;53(6):725-739. doi: 10.1007/s00535-017-1408-0. Epub 2017 Nov 4.
5
Circular RNA circ-PVT1 contributes to paclitaxel resistance of gastric cancer cells through the regulation of ZEB1 expression by sponging miR-124-3p.环状 RNA circ-PVT1 通过海绵吸附 miR-124-3p 调控 ZEB1 表达促进胃癌细胞对紫杉醇耐药。
Biosci Rep. 2019 Dec 20;39(12). doi: 10.1042/BSR20193045.
6
miR-146b Regulates Cell Proliferation and Apoptosis in Gastric Cancer by Targeting PTP1B.miR-146b 通过靶向 PTP1B 调节胃癌细胞增殖和凋亡。
Dig Dis Sci. 2020 Feb;65(2):457-463. doi: 10.1007/s10620-019-05771-8. Epub 2019 Aug 22.
7
MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers.MicroRNA-409 通过直接靶向胃癌中的 radixin 抑制肿瘤细胞侵袭和转移。
Oncogene. 2012 Oct 18;31(42):4509-16. doi: 10.1038/onc.2011.581. Epub 2011 Dec 19.
8
LINC00240 promotes gastric cancer cell proliferation, migration and EMT via the miR-124-3p / DNMT3B axis.LINC00240 通过 miR-124-3p/DNMT3B 轴促进胃癌细胞增殖、迁移和 EMT。
Cell Biochem Funct. 2020 Dec;38(8):1079-1088. doi: 10.1002/cbf.3551. Epub 2020 Jun 11.
9
PTP1B markedly promotes breast cancer progression and is regulated by miR-193a-3p.PTP1B 显著促进乳腺癌的进展,并受 miR-193a-3p 调控。
FEBS J. 2019 Mar;286(6):1136-1153. doi: 10.1111/febs.14724. Epub 2018 Dec 26.
10
miR-25-3p inhibition impairs tumorigenesis and invasion in gastric cancer cells and .miR-25-3p 抑制可损害胃癌细胞的肿瘤发生和侵袭能力。
Bioengineered. 2020 Dec;11(1):81-90. doi: 10.1080/21655979.2019.1710924.

引用本文的文献

1
Extracellular Microvesicle MicroRNAs and Imaging Metrics Improve the Detection of Aggressive Prostate Cancer: A Pilot Study.细胞外微泡微小RNA与成像指标改善侵袭性前列腺癌的检测:一项初步研究
Cancers (Basel). 2025 Feb 27;17(5):835. doi: 10.3390/cancers17050835.
2
Modelling of miRNA-mRNA Network to Identify Gene Signatures with Diagnostic and Prognostic Value in Gastric Cancer: Evidence from and Studies.构建miRNA-mRNA网络以鉴定具有胃癌诊断和预后价值的基因特征:来自[具体研究]和[具体研究]的证据
Rep Biochem Mol Biol. 2024 Jul;13(2):281-300. doi: 10.61186/rbmb.13.2.281.
3
PLASMA: Partial LeAst Squares for Multiomics Analysis.

本文引用的文献

1
Protein tyrosine phosphatase 1B expression contributes to the development of breast cancer.蛋白酪氨酸磷酸酶1B的表达促进乳腺癌的发展。
J Zhejiang Univ Sci B. 2017;18(4):334-342. doi: 10.1631/jzus.B1600184.
2
Molecular Pathways: Targeting Protein Tyrosine Phosphatases in Cancer.分子途径:癌症中靶向蛋白酪氨酸磷酸酶
Clin Cancer Res. 2017 May 1;23(9):2136-2142. doi: 10.1158/1078-0432.CCR-16-0934. Epub 2017 Jan 13.
3
EMT: 2016.EMT:2016 年。
血浆:用于多组学分析的偏最小二乘法
Cancers (Basel). 2025 Jan 17;17(2):287. doi: 10.3390/cancers17020287.
4
The role of MAPK pathway in gastric cancer: unveiling molecular crosstalk and therapeutic prospects.丝裂原活化蛋白激酶(MAPK)通路在胃癌中的作用:揭示分子间相互作用及治疗前景
J Transl Med. 2024 Dec 24;22(1):1142. doi: 10.1186/s12967-024-05998-8.
5
Protein tyrosine phosphatase 1B in metabolic and cardiovascular diseases: from mechanisms to therapeutics.蛋白酪氨酸磷酸酶1B在代谢性疾病和心血管疾病中的作用:从机制到治疗
Front Cardiovasc Med. 2024 Aug 22;11:1445739. doi: 10.3389/fcvm.2024.1445739. eCollection 2024.
6
Extracellular microvesicle microRNAs, along with imaging metrics, improve detection of aggressive prostate cancer.细胞外微泡微小核糖核酸与成像指标一起,可提高侵袭性前列腺癌的检测率。
medRxiv. 2024 Aug 23:2024.08.23.24312491. doi: 10.1101/2024.08.23.24312491.
7
Association of miR-338-3p with survival outcomes in gastric cancer patients who received peri-operative blood transfusion.接受围手术期输血的胃癌患者中miR-338-3p与生存结局的关联
Clin Transl Oncol. 2025 Feb;27(2):604-611. doi: 10.1007/s12094-024-03628-9. Epub 2024 Aug 4.
8
MicroRNA biomarkers as next-generation diagnostic tools for neurodegenerative diseases: a comprehensive review.微小RNA生物标志物作为神经退行性疾病的下一代诊断工具:综述
Front Mol Neurosci. 2024 May 31;17:1386735. doi: 10.3389/fnmol.2024.1386735. eCollection 2024.
9
CircDiaph3 aggravates H/R-induced cardiomyocyte apoptosis and inflammation through miR-338-3p/SRSF1 axis.环状 RNA CircDiaph3 通过 miR-338-3p/SRSF1 轴加剧 H/R 诱导的心肌细胞凋亡和炎症。
J Bioenerg Biomembr. 2024 Jun;56(3):235-245. doi: 10.1007/s10863-023-09992-5. Epub 2024 Apr 13.
10
Editorial: Novel advances in gastrointestinal cancer treatment.社论:胃肠道癌治疗的新进展
Front Mol Biosci. 2023 Jun 30;10:1238098. doi: 10.3389/fmolb.2023.1238098. eCollection 2023.
Cell. 2016 Jun 30;166(1):21-45. doi: 10.1016/j.cell.2016.06.028.
4
OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer.致癌miRNA还是肿瘤抑制因子?微小RNA在癌症中的两面性
Cancer Res. 2016 Jul 1;76(13):3666-70. doi: 10.1158/0008-5472.CAN-16-0359. Epub 2016 Jun 20.
5
MicroRNA-338-3p suppresses metastasis of lung cancer cells by targeting the EMT regulator Sox4.微小RNA-338-3p通过靶向上皮-间质转化调节因子Sox4抑制肺癌细胞的转移。
Am J Cancer Res. 2016 Jan 15;6(2):127-40. eCollection 2016.
6
Increased PTP1B expression and phosphatase activity in colorectal cancer results in a more invasive phenotype and worse patient outcome.结直肠癌中蛋白酪氨酸磷酸酶1B(PTP1B)表达增加及磷酸酶活性增强会导致更具侵袭性的表型和更差的患者预后。
Oncotarget. 2016 Apr 19;7(16):21922-38. doi: 10.18632/oncotarget.7829.
7
Protein tyrosine phosphatase 1B dephosphorylates PITX1 and regulates p120RasGAP in hepatocellular carcinoma.蛋白酪氨酸磷酸酶 1B 去磷酸化 PITX1 并调节肝癌中的 p120RasGAP。
Hepatology. 2016 May;63(5):1528-43. doi: 10.1002/hep.28478. Epub 2016 Mar 2.
8
MiR-338-3p inhibits the proliferation and migration of gastric cancer cells by targeting ADAM17.微小RNA-338-3p通过靶向解聚素金属蛋白酶17抑制胃癌细胞的增殖和迁移。
Int J Clin Exp Pathol. 2015 Sep 1;8(9):10922-8. eCollection 2015.
9
MicroRNA-338-3p functions as tumor suppressor in breast cancer by targeting SOX4.微小 RNA-338-3p 通过靶向 SOX4 在乳腺癌中发挥肿瘤抑制作用。
Int J Oncol. 2015 Oct;47(4):1594-602. doi: 10.3892/ijo.2015.3114. Epub 2015 Aug 6.
10
MicroRNA biogenesis pathways in cancer.癌症中的微小RNA生物合成途径。
Nat Rev Cancer. 2015 Jun;15(6):321-33. doi: 10.1038/nrc3932.